Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma

Published:2019-06-03 Issue:8 Volume:39 Page:1468-1477
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Faivre Sandrine¹,Santoro Armando²,Kelley Robin K.³,Gane Ed⁴,Costentin Charlotte E.⁵^ORCID,Gueorguieva Ivelina⁶,Smith Claire⁶,Cleverly Ann⁶,Lahn Michael M.⁷,Raymond Eric⁸,Benhadji Karim A.⁷,Giannelli Gianluigi⁹

Affiliation:

1. Oncologie Médicale Hopital Beaujon Clichy France

2. Istituto Clinico Humanitas Humanitas University Rozzano Italy

3. University of California San Francisco CA

4. Auckland City Hospital Auckland New Zealand

5. Hospital Henri Mondor Creteil France

6. Lilly Research Centre Erl Wood Manor Windlesham UK

7. Eli Lilly and Company Indianapolis IN

8. Centre Hospitalier Paris Saint‐Joseph Paris France

9. National Institute of Gastroenterology Research Instituts “S. De Bellis” Research Hospital, Castellana Grotte Bari Italy

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14113

Reference35 articles.

1. Epidemiology of Hepatocellular Carcinoma

2. Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

5. Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of its treatment with sorafenib [Sor]) in >3000 Sor‐treated patients (pts): clinical findings in pts with liver dysfunction. 2013 ASCO Annual Meeting, 2013. Chicago;Marrero JA;ASCOJ Clin Oncol,2013

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapies for Hepatocellular Carcinoma Treatment;Liver Cancer - Multidisciplinary Approach;2024-09-11

2. Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies;Frontiers in Pharmacology;2024-09-02

3. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution;Journal of Hematology & Oncology;2024-09-02

4. Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma;Pharmacological Research;2024-09

5. Structure, unique biological properties, and mechanisms of action of transforming growth factor β;Bioorganic Chemistry;2024-09